Anaptysbio (ANAB) Times Interest Earned (2016 - 2019)
Anaptysbio (ANAB) reported Times Interest Earned of -$111.29 for Q4 2019, down 106.59% on a YoY basis from $1690.0 in Q4 2018, and up 20.85% quarter-over-quarter from -$140.6 in Q3 2019.
Anaptysbio (ANAB) Times Interest Earned (2016 - 2019) Analysis & Trends
Anaptysbio has reported Times Interest Earned for 4 years, with the latest figure at -$111.29 in Q4 2019.
- For the quarter ending Q4 2019, Times Interest Earned fell 106.59% year-over-year to -$111.29; the trailing twelve-month figure through Sep 2020 stood at -$397.41 (down 357.16% YoY), and the FY2019 full-year result was -$103.2, down 155.52% from the prior year.
- Times Interest Earned for Q4 2019 stood at -$111.29, up from -$140.6 in the prior quarter.
- The five-year high for Times Interest Earned was $20.37 in Q2 2016, with the low at -$140.6 in Q3 2019.
- Historically, Times Interest Earned has averaged -$42.54 across 4 years, with a median of -$30.83 in 2016.
- Annual changes were most pronounced in 2017 — Times Interest Earned jumped 45.16% — and 2018, when it plunged 468.07%.
- Anaptysbio's Times Interest Earned stood at -$28.59 in 2016, then surged by 45.16% to -$15.68 in 2017, then tumbled by 243.52% to -$53.87 in 2018, then tumbled by 106.59% to -$111.29 in 2019.
- The last three Times Interest Earned figures came in at -$111.29 (Q4 2019), -$140.6 (Q3 2019), and -$94.86 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -111.29 |
| Sep 30, 2019 | -140.60 |
| Jun 30, 2019 | -94.86 |
| Mar 31, 2019 | -77.41 |
| Dec 31, 2018 | -53.87 |
| Sep 30, 2018 | -42.22 |
| Jun 30, 2018 | -33.06 |
| Mar 31, 2018 | -34.94 |
| Dec 31, 2017 | -15.68 |
| Sep 30, 2017 | -20.10 |
| Jun 30, 2017 | -5.82 |
| Mar 31, 2017 | -23.34 |
| Dec 31, 2016 | -28.59 |
| Sep 30, 2016 | -9.27 |
| Jun 30, 2016 | 20.37 |
| Mar 31, 2016 | -9.90 |